Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Colorectal Cancer × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Nasopharyngeal Carcinoma 6 Melanoma 3 Lung Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell 2 Colorectal Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Recurrence 1 Pleural Effusion, Malignant 1 Osteosarcoma 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1 Advanced Colorectal Cancer 1

Interventions

Oxaliplatin 3 Cetuximab 3 Capecitabine 3 Irinotecan 2 trifluridine tipiracil drug combination 1 surufatinib 1 regorafenib 1 raltitrexed 1 plocabulin 1 nimotuzumab 1 irinotecan sucrosofate 1 endostar protein 1 durvalumab 1 defactinib 1 Panitumumab 1 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1 Drug Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00853684 2009-09-18

OXCE

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡